The Global Market for Travel Vaccines (2018-2022) with GlaxoSmithKline, Pfizer, Sanofi and Valneva Dominating - ResearchAndMarkets.com
DUBLIN--(BUSINESS WIRE)--Jan 3, 2019--The “Global Travel Vaccines Market 2018-2022” report has been added to ResearchAndMarkets.com’s offering.
The travel vaccines market will register a CAGR of almost 10% by 2022.
Increased incidence of travel-related diseases is expected to drive the market growth
Traveling is often associated with higher health risks especially regarding infectious diseases. Thus, the rising incidence of travel related diseases will lead to more investments in the global travel vaccines market for the development of more effective vaccines.
Increase in global travel and migration
With the rise in traveling over the past few years has resulted in the spread of pathogens and disease-causing vectors worldwide. The increase in travel and migration offers huge opportunities to the manufacturers to invest in the R&D of new and more effective vaccines.
High cost of travel vaccinations
Travel clinics offer vaccinations at a slightly higher price and new vaccines are usually more expensive.
Key PlayersGlaxoSmithKline Pfizer Sanofi Valneva
PART 01: EXECUTIVE SUMMARY
PART 02: SCOPE OF THE REPORT
PART 03: RESEARCH METHODOLOGY
PART 04: MARKET LANDSCAPEMarket ecosystem Market characteristics Market segmentation analysis
PART 05: PIPELINE ANALYSIS
PART 06: MARKET SIZINGMarket definition Market sizing 2017 Market size and forecast 2017-2022
PART 07: FIVE FORCES ANALYSIS
PART 08: MARKET SEGMENTATION BY TARGET DISEASE FOR IMMUNIZATIONSegmentation by target disease for immunization Comparison by target disease for immunization Influenza - Market size and forecast 2017-2022 Diphtheria - Market size and forecast 2017-2022 Others - Market size and forecast 2017-2022 Hepatitis - Market size and forecast 2017-2022 Typhoid - Market size and forecast 2017-2022 Polio - Market size and forecast 2017-2022 Yellow fever - Market size and forecast 2017-2022 Market opportunity by target disease
PART 09: CUSTOMER LANDSCAPE
PART 10: REGIONAL LANDSCAPE
PART 11: DECISION FRAMEWORK
PART 12: DRIVERS AND CHALLENGES
PART 13: MARKET TRENDSChanges in the demographic profile of travelers globally Increased incidence of travel-related diseases Initiatives by governments and other organizations to ensure travel safety Evolving epidemiological patterns of infectious diseases in different countries
PART 14: VENDOR LANDSCAPEOverview Landscape disruption
PART 15: VENDOR ANALYSISVendors covered Vendor classification Market positioning of vendors GlaxoSmithKline Pfizer Sanofi Valneva
For more information about this report visit https://www.researchandmarkets.com/research/q5xj77/the_global_market?w=4
View source version on businesswire.com:https://www.businesswire.com/news/home/20190103005320/en/
Laura Wood, Senior Press Manager
For E.S.T Office Hours Call 1-917-300-0470
For U.S./CAN Toll Free Call 1-800-526-8630
For GMT Office Hours Call +353-1-416-8900
INDUSTRY KEYWORD: HEALTH INFECTIOUS DISEASES PHARMACEUTICAL
SOURCE: Research and Markets
Copyright Business Wire 2019.
PUB: 01/03/2019 06:46 AM/DISC: 01/03/2019 06:45 AM